Literature DB >> 1700126

The rise and fall of Escherichia coli O15 in a London teaching hospital.

P M O'Neill1, C A Talboys, A P Roberts, B S Azadian.   

Abstract

A marked increase in the prevalence of bacteraemia due to Escherichia coli of serogroup O15 was noted during November and December 1986 at Charing Cross Hospital. This multiresistant strain had been reported by several hospitals in south London. All isolates of E. coli from patients with bacteraemia between October 1986 and the end of September 1988 were assessed for the presence of the O15 antigen and for the unusual pattern of resistance to six antimicrobial agents. As a guide to faecal carriage, isolates from urine were similarly assessed during seven 4-week periods between January 1987 and June 1988. Of the 123 E. coli isolates from blood, 25 (20%) were serogroup O15 and 20 of these expressed the same pattern of multiresistance; 17 of these multiresistant isolates occurred in the 4-month period 1 Nov. 1986-28 Feb. 1987. During the remaining 19 months of the study only eight isolates were serogroup O15 of which only three were multiresistant. In the first 4-week period that urine isolates were studied 21 Jan. 1987-17 Feb. 1987, 26 (13.2%) of the 195 isolates were serogroup O15 of which 20 were multiresistant. The proportion of serogroup O15 isolates fell gradually until, in June 1988, the last period studied, only 8 (4.2%) of the 189 isolates were serogroup O15, of which only one was multiresistant. In a preliminary study of plasmids in six serogroup O15 isolates from blood, three multiresistant isolates and one that was sensitive to chloramphenicol appeared to carry a similar plasmid of c. 100 Mda.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700126     DOI: 10.1099/00222615-33-1-23

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  11 in total

1.  Escherichia coli serotype O15:K52:H1 as a uropathogenic clone.

Authors:  G Prats; F Navarro; B Mirelis; D Dalmau; N Margall; P Coll; A Stell; J R Johnson
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe.

Authors:  James R Johnson; Adam L Stell; Timothy T O'Bryan; Michael Kuskowski; Bogdan Nowicki; Candice Johnson; Joel N Maslow; Anil Kaul; Justine Kavle; Guillem Prats
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 3.  The epidemiology of urinary tract infection.

Authors:  Betsy Foxman
Journal:  Nat Rev Urol       Date:  2010-12       Impact factor: 14.432

4.  Rapid Emergence, Subsidence, and Molecular Detection of Escherichia coli Sequence Type 1193-fimH64, a New Disseminated Multidrug-Resistant Commensal and Extraintestinal Pathogen.

Authors:  James R Johnson; Brian D Johnston; Stephen B Porter; Connie Clabots; Tricia L Bender; Paul Thuras; Darren J Trott; Rowland Cobbold; Joanne Mollinger; Patricia Ferrieri; Sarah Drawz; Ritu Banerjee
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

5.  Sequence analysis of the Escherichia coli O15 antigen gene cluster and development of a PCR assay for rapid detection of intestinal and extraintestinal pathogenic E. coli O15 strains.

Authors:  Lothar Beutin; Jiang Tao; Lu Feng; Gladys Krause; Sonja Zimmermann; Kerstin Gleier; Qiuyu Xia; Lei Wang
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

6.  The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics.

Authors:  Ritu Banerjee; Brian Johnston; Christine Lohse; Sujay Chattopadhyay; Veronika Tchesnokova; Evgeni V Sokurenko; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

7.  Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004.

Authors:  James R Johnson; Megan Menard; Brian Johnston; Michael A Kuskowski; Kim Nichol; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

8.  Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis.

Authors:  Richard Colgan; James R Johnson; Michael Kuskowski; Kalpana Gupta
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

9.  Rapid and specific detection of the O15:K52:H1 clonal group of Escherichia coli by gene-specific PCR.

Authors:  James R Johnson; Krista Owens; Montse Sabate; Guillem Prats
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

10.  Escherichia coli Sequence Type 131 H30 Is the Main Driver of Emerging Extended-Spectrum-β-Lactamase-Producing E. coli at a Tertiary Care Center.

Authors:  James R Johnson; Brian Johnston; Paul Thuras; Bryn Launer; Evgeni V Sokurenko; Loren G Miller
Journal:  mSphere       Date:  2016-11-23       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.